To confirm that MAPKAPK5-AS1 participated in HCC development by regulating miR-429 expression, we successfully constructed miR-429 low expression model in HCC cell line using miR-429 inhibitors (Fig. 4E). The gene discussed is MAPKAPK5; the disease is hepatocellular carcinoma.